Effect of therapy with human recombinant growth hormone for 3 and 6 months on left ventricular size and function in patients with dilated cardiomyopathy

被引：0
|
作者：
Osterziel, KJ
Strohm, O
Hamann, K
Ellmer, AE
Ranke, MB
Dietz, R
机构：
[1] Humboldt Univ, Charite Franz Volhard Clin, Berlin, Germany
[2] Kinderklin Univ, Tuebingen, Germany
来源：
CIRCULATION | 1998年 / 98卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3048
引用
收藏
页码：579 / 579
页数：1
相关论文
共 50 条
  • [31] Changes in human Golgi apparatus reflect new left ventricular dimensions and function in dilated cardiomyopathy patients
    Tarazon, Estefania
    Rosello-Lleti, Esther
    Ortega, Ana
    Gil-Cayuela, Carolina
    Gonzalez-Juanatey, Jose Ramon
    Lago, Francisca
    Martinez-Dolz, Luis
    Portoles, Manuel
    Rivera, Miguel
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (02) : 280 - 282
  • [32] Recombinant human growth hormone delivered by tissueengineered bioartificial muscle improves left ventricular function
    Rong, S. L.
    Lu, Y. X.
    Liao, Y. H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2007, 6 : 99 - 99
  • [33] Effect of left atrial function on cardiovascular outcome in non-dilated left ventricular cardiomyopathy
    Kang, J. M.
    Song, S.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [34] Prophylactic implantable cardioverter defibrillator therapy in dilated cardiomyopathy: Impact of left ventricular function
    Schaer, BA
    Ammann, P
    Sticherling, C
    Zellweger, MJ
    Cron, TA
    Osswald, S
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 108 (01) : 26 - 30
  • [35] Ventricular function in patients with dilated cardiomyopathy is improved by VDD pacing at left but not right ventricular sites
    Kass, DA
    Chen, CH
    Fetics, B
    Talbot, M
    Nevo, E
    Nakayama, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 31A - 31A
  • [36] Nitric oxide may mediate the vasodilatory effect of growth hormone therapy in patients with dilated cardiomyopathy
    Osterziel, KJ
    Strohm, O
    Ellmer, AE
    Ranke, MB
    Bode-Boeger, SM
    Boeger, RH
    CIRCULATION, 1998, 98 (17) : 248 - 248
  • [37] Six months of recombinant human GH therapy in patients with ischemic cardiac failure does not influence left ventricular function and mass
    Smit, JWA
    Janssen, YJH
    Lamb, HJ
    van der Wall, EE
    Stokkel, MPM
    Viergever, E
    Biermasz, NR
    Bax, JJ
    Vliegen, HW
    de Roos, A
    Romijn, JA
    Roelfsema, F
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (10): : 4638 - 4643
  • [38] The effects of recombinant human growth hormone therapy on thyroid function in pediatric patients with growth hormone deficiency
    Yao, Qian
    Zheng, Dong
    Liang, Yan
    Hou, Ling
    Ying, Yan-Qin
    Luo, Xiao-Ping
    Wu, Wei
    TRANSLATIONAL PEDIATRICS, 2021, 10 (04) : 851 - 859
  • [39] The influence of left ventricular diameter on left atrial appendage size and thrombus formation in patients with dilated cardiomyopathy
    Bakalli, Aurora
    Kamberi, Lulzim
    Pllana, Ejup
    Zahiti, Bedri
    Dragusha, Gani
    Brovina, Ahmet
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2010, 38 (02): : 90 - 94
  • [40] Effects of growth hormone on circulating cytokine network, and left ventricular contractile performance and geometry in patients with idiopathic dilated cardiomyopathy
    Adamopoulos, S
    Parissis, JT
    Paraskevaidis, I
    Karatzas, D
    Livanis, E
    Georgiadis, M
    Karavolias, G
    Mitropoulos, D
    Degiannis, D
    Kremastinos, DT
    EUROPEAN HEART JOURNAL, 2003, 24 (24) : 2186 - 2196
12345